NRD
MDXG icon

Nebula Research & Development’s MiMedx Group MDXG Stock Holding History

Nebula Research & Development’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-22,587
Closed -$133K – 1026
2024
Q3 		$133K Sell
22,587
-15,884
-41% -$105K 0.02% 861
2024
Q2 		$267K Buy
38,471
+3,665
+11% +$25.8K 0.04% 639
2024
Q1 		$268K Buy
+34,806
New +$280K 0.06% 571

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nebula Research & Development's MDXG Position: Q4 2024 in Review

Nebula Research & Development sold out of MiMedx Group (MDXG) in Q4 2024, closing a stake of 22,587 shares — an estimated $133K sold.

Nebula Research & Development first reported a position in MDXG in Q1 2024 and held it in 3 quarters. The position peaked at $268K in Q1 2024. 213 funds tracked by Wall St. Rank hold MDXG as of Q4 2024.

  • Nebula Research & Development reported no remaining MiMedx Group position as of Q4 2024 after selling out during the quarter.
  • Nebula Research & Development sold 22,587 MiMedx Group shares in Q4 2024, an estimated $133K.
  • Nebula Research & Development first reported a position in MiMedx Group in Q1 2024 and held it in 3 quarters.
  • Nebula Research & Development's MiMedx Group position peaked at $268K in Q1 2024.
  • 213 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2024.

Based on Nebula Research & Development's 13F filing for Q4 2024, filed 14 Feb 2025.